Floatz logo

Solu-Cortef

Radiation-Induced Dermatitis

OHSU Knight Cancer InstituteN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

11 Active assets in the Radiation-Induced Dermatitis cohort.

Asset / SponsorPhaseRating
Urea
University of Brasilia
Phase 3BB
Olea europaea oil
Cairo University
Phase 4BB
BETAMETHASONE
Cairo University
Phase 4BB
Chamomilla recutita
University of Brasilia
Phase 3BB
Mometasone
North Central Cancer Treatment Group
Phase 3BB

View all 33 →

Same molecule, other indications

Solu-Cortef is also rated in:

congenital adrenal hyperplasiaDormant
A
Indicative ·
81 / 100
View asset →
childhood acute lymphoblastic leukemiaDormant
BB
Indicative ·
68 / 100
View asset →
myelodysplastic syndromeDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →